In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, discuss recent regulatory and policy developments.

Register now – Dec. 10, 2025 - This webinar explores the rapidly evolving field of pharmacogenomics, with a special focus on the DPYD gene and its significance in oncology.

In the third quarter of 2025, Mayo Clinic Laboratories expanded its test catalog with several innovative new tests.

This microlearning will familiarize users on MCL's AI-augmented kidney stone test along with the proper procedures for collecting and processing kidney stones to provide accurate, cost-effective, and timely analysis of the stones.

Artificial intelligence (AI) is reshaping laboratory medicine, not as a distant promise, but as a practical tool improving diagnostics, workflows, and quality. Through collaborative development, rigorous validation, and a commitment to ethical innovation, Mayo Clinic Laboratories is implementing AI-driven solutions that enhance precision, reduce turnaround times, and empower laboratorians to focus on what matters most: patient care.

Review ways of problem-solving through MDI and how it can best be applied in the workplace.

Ticks and mosquitoes are small but dangerous vectors that transmit a range of serious diseases, including Lyme disease, anaplasmosis, West Nile virus, and dengue. The severity of tick and mosquito seasons is influenced by environmental factors like climate, habitat, and host availability, and experts warn that rising temperatures may increase both the spread and complexity of these infections.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and Elitza Theel, Ph.D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic, discuss the latest developments in self-collection testing for women’s health and beyond.

Breaking away from an 80-year-old testing approach used to identify neurosyphilis infections, Mayo Clinic Laboratories has introduced a new, highly sensitive and specific method to confirm disease presence. The innovative test – the only one of its kind available in the U.S. – is IgG antibody index that detects antibodies specific to the disease-causing agent Treponema pallidum.

Learn five ways to accelerate diagnostic innovation while safeguarding patient trust, data integrity, and regulatory readiness.

In this episode of the “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, is joined by colleagues Wendy Daigle and Ellen Dijkman Dulkes. Together, they dive into the power of communication in laboratory outreach, sharing practical advice and memorable stories.

Christopher Garcia, M.D., chief digital innovation officer at Mayo Clinic Laboratories, shares how laboratories can use AI to expand access to data, personalize care, and transform the future of diagnostics.

Effective communication in laboratory outreach hinges on understanding what to share, who needs to hear it, and how urgently it must be conveyed.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, discuss troublesome organisms making headlines.

The registration deadline for Mayo Clinic Laboratories Education’s first-ever virtual phlebotomy workshop on Oct. 1 is fast approaching. Register today.